Glaukos

GKOS

0 Followers

$90.52

+2.58%

$2.28

30 July

Upcoming Earnings

Market Cap.

P/E

Overview Metrics Financials

GKOS Fair Price

$73.34

Overvalued by 45.0%

To display the fair price of a share, you need to be a member of Bulios Black.

My Notes

Začít psát

Profile

Glaukos Corporation is an American biotechnology company focused on the development and manufacture of innovative ophthalmic products. Founded in 1998, its headquarters are located in San Clemente, California. Glaukos specializes in the treatment of glaucoma and other eye diseases using new technologies, including implants and micro-surgical solutions. The company focuses on improving patients' quality of life through groundbreaking products and services that bring innovation to the field of ophthalmology.

Feed

There are no posts to show right now.